Atlas Trials

Convergent Therapeutics

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Convergent Therapeutics

RecordFirmDate
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC) (NCT06549465)Convergent Therapeutics2024-08-06

Track Convergent Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.